Fortis Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-524
| Closed | -$261K | – | 180 |
|
2025
Q1 | $261K | Sell |
524
-694
| -57% | -$345K | 0.05% | 129 |
|
2024
Q4 | $633K | Sell |
1,218
-381
| -24% | -$198K | 0.12% | 89 |
|
2024
Q3 | $989K | Buy |
1,599
+80
| +5% | +$49.5K | 0.2% | 76 |
|
2024
Q2 | $840K | Sell |
1,519
-5,963
| -80% | -$3.3M | 0.18% | 80 |
|
2024
Q1 | $4.35M | Buy |
7,482
+811
| +12% | +$471K | 1.14% | 16 |
|
2023
Q4 | $3.54M | Buy |
6,671
+432
| +7% | +$229K | 0.91% | 21 |
|
2023
Q3 | $3.16M | Buy |
6,239
+4,546
| +269% | +$2.3M | 0.98% | 21 |
|
2023
Q2 | $883K | Buy |
1,693
+119
| +8% | +$62.1K | 0.31% | 58 |
|
2023
Q1 | $907K | Buy |
1,574
+265
| +20% | +$153K | 0.37% | 51 |
|
2022
Q4 | $721K | Sell |
1,309
-44
| -3% | -$24.2K | 0.53% | 45 |
|
2022
Q3 | $686K | Buy |
+1,353
| New | +$686K | 0.59% | 49 |
|
2021
Q4 | – | Sell |
-3,332
| Closed | -$1.9M | – | 107 |
|
2021
Q3 | $1.9M | Sell |
3,332
-900
| -21% | -$514K | 1.01% | 38 |
|
2021
Q2 | $2.14M | Hold |
4,232
| – | – | 1.09% | 43 |
|
2021
Q1 | $1.93M | Buy |
+4,232
| New | +$1.93M | 1.11% | 55 |
|